DK0804562T3 - Bindevævsvækstfaktor-2 - Google Patents

Bindevævsvækstfaktor-2

Info

Publication number
DK0804562T3
DK0804562T3 DK94925090T DK94925090T DK0804562T3 DK 0804562 T3 DK0804562 T3 DK 0804562T3 DK 94925090 T DK94925090 T DK 94925090T DK 94925090 T DK94925090 T DK 94925090T DK 0804562 T3 DK0804562 T3 DK 0804562T3
Authority
DK
Denmark
Prior art keywords
polypeptide
growth factor
connective tissue
tissue growth
enhancing
Prior art date
Application number
DK94925090T
Other languages
English (en)
Inventor
Haodong Li
D Adams Mark
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Application granted granted Critical
Publication of DK0804562T3 publication Critical patent/DK0804562T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
DK94925090T 1994-07-12 1994-07-12 Bindevævsvækstfaktor-2 DK0804562T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/007736 WO1996001896A1 (en) 1994-07-12 1994-07-12 Connective tissue growth factor-2

Publications (1)

Publication Number Publication Date
DK0804562T3 true DK0804562T3 (da) 2003-02-10

Family

ID=22242737

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94925090T DK0804562T3 (da) 1994-07-12 1994-07-12 Bindevævsvækstfaktor-2

Country Status (10)

Country Link
US (5) US5945300A (da)
EP (2) EP0804562B1 (da)
JP (1) JPH10502534A (da)
AT (1) ATE225850T1 (da)
AU (1) AU689492B2 (da)
DE (1) DE69431534T2 (da)
DK (1) DK0804562T3 (da)
NZ (1) NZ271488A (da)
PT (1) PT804562E (da)
WO (1) WO1996001896A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804562B1 (en) * 1994-07-12 2002-10-09 Human Genome Sciences, Inc. Connective tissue growth factor-2
AU2004202578B2 (en) * 1996-03-15 2007-09-13 Munin Corporation Extracellular matrix signalling molecules
CA2248549A1 (en) * 1996-03-15 1997-09-18 Munin Corporation Extracellular matrix signalling molecules
US6790606B1 (en) 1996-03-15 2004-09-14 Munin Corporation Extracellular matrix signaling molecules
US7521540B2 (en) 1996-03-15 2009-04-21 Munin Corporation CYR61 compositions and methods
US20090081228A1 (en) * 1996-03-15 2009-03-26 Munin Corporation Cyr61 compositions and methods
US20040132987A1 (en) 1996-11-08 2004-07-08 Human Genome Sciences, Inc. Connective tissue growth factor-3
CA2286934A1 (en) * 1997-04-16 1998-10-22 Millennium Pharmaceuticals, Inc. Novel polypeptides within the growth factor superfamily
DE19719652A1 (de) * 1997-05-09 1998-12-03 Merckle Gmbh Tissue-Faktor zur Förderung von Wundheilung
EP1019503A4 (en) * 1997-08-06 2003-04-23 Millennium Pharm Inc NUCLEIC ACID MOLECULES AND POLYPEPTIDES TANGO-71, TANGO-73, TANGO-74, TANGO-76 AND TANGO-83
US5876730A (en) * 1997-08-07 1999-03-02 Childrens Hospital Research Foundation Heparin-binding growth factor (HBGF) polypeptides
AU2870399A (en) * 1998-02-20 1999-09-06 Zymogenetics Inc. Connective tissue growth factor homologs
US6378527B1 (en) * 1998-04-08 2002-04-30 Chondros, Inc. Cell-culture and polymer constructs
EP1140964B1 (en) * 1998-12-14 2008-04-09 University Of Miami Connective tissue growth factor (ctgf) fragment
US7115390B1 (en) * 1998-12-14 2006-10-03 Fibrogen, Inc. Connective tissue growth factor fragments and methods and uses thereof
EP1892250A3 (en) * 2000-01-31 2008-09-17 Munin Corporation CYR61 compositions and methods
US20060052328A1 (en) * 2000-07-11 2006-03-09 Human Genome Sciences, Inc. Connective tissue growth factor-2
WO2005033136A1 (en) * 2003-09-29 2005-04-14 Children's Hospital, Inc. Unique integrin binding site in connective tissue growth factor (ctgf)
TW201102086A (en) 2009-06-04 2011-01-16 Hoffmann La Roche Antibodies against human CCN1 and uses thereof
WO2011107590A1 (en) * 2010-03-04 2011-09-09 Wolfgang Poller Cnn1 (cyr61) for prevention and therapy of inflammatory disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289584B1 (en) 1986-11-14 1993-05-05 Institute of Molecular Biology, Inc. Wound healing and bone regeneration
DK131988A (da) 1988-03-11 1989-09-12 Erasmus University Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
US5648461A (en) * 1990-02-22 1997-07-15 W.R. Grace & Co.-Conn Synthetic analogs of thrombospondin and therapeutic use thereof
EP0495674A3 (en) * 1991-01-18 1993-09-01 Bristol-Myers Squibb Company Tgf-beta induced gene family
US5837258A (en) 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US5408040A (en) * 1991-08-30 1995-04-18 University Of South Florida Connective tissue growth factor(CTGF)
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
WO1994003599A1 (fr) 1992-08-04 1994-02-17 Sagami Chemical Research Center ADNc HUMAIN ET PROTEINE POUR LAQUELLE CODE CET ADNc
US7026299B2 (en) * 1994-07-12 2006-04-11 Human Genome Sciences, Inc. Connective tissue growth factor-2
EP0804562B1 (en) * 1994-07-12 2002-10-09 Human Genome Sciences, Inc. Connective tissue growth factor-2
US5792453A (en) 1995-02-28 1998-08-11 The Regents Of The University Of California Gene transfer-mediated angiogenesis therapy
CA2248549A1 (en) 1996-03-15 1997-09-18 Munin Corporation Extracellular matrix signalling molecules
US5944710A (en) 1996-06-24 1999-08-31 Genetronics, Inc. Electroporation-mediated intravascular delivery
EP1140964B1 (en) 1998-12-14 2008-04-09 University Of Miami Connective tissue growth factor (ctgf) fragment
US20060052328A1 (en) * 2000-07-11 2006-03-09 Human Genome Sciences, Inc. Connective tissue growth factor-2

Also Published As

Publication number Publication date
EP0804562B1 (en) 2002-10-09
DE69431534T2 (de) 2003-06-26
US5945300A (en) 1999-08-31
ATE225850T1 (de) 2002-10-15
AU7513194A (en) 1996-02-09
NZ271488A (en) 1998-01-26
EP0804562A4 (en) 1998-08-05
WO1996001896A1 (en) 1996-01-25
US6534630B1 (en) 2003-03-18
US20100041136A1 (en) 2010-02-18
EP0804562A1 (en) 1997-11-05
JPH10502534A (ja) 1998-03-10
DE69431534D1 (de) 2002-11-14
AU689492B2 (en) 1998-04-02
EP1217067A2 (en) 2002-06-26
PT804562E (pt) 2003-02-28
US20030078391A1 (en) 2003-04-24
US20070154908A1 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
ATE225850T1 (de) Bindegewebswachstumsfaktor-2
DK0759067T3 (da) Transformerende vækstfaktor alfa-H1
DK0751992T3 (da) Karendotelvækstfaktor 2
PT735818E (pt) Proteinas inflamatorias de macrofagos pim-3 pim-4 e pim-1y
DE10299044I1 (de) n-Terminal chemisch modifizierte Protein-Zusammensetzungen und Methoden
ATE259243T1 (de) Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse
ATE295734T1 (de) Verwendung von fibroblasten-wachstumsfaktor analogen zur stimulation des knochenwachstums
DK0429570T3 (da) Osteoinducerende præparater
ATE238417T1 (de) Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
ATE153696T1 (de) Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein
EE200200386A (et) Nogo-retseptoriga vahendatud aksonikasvu blokaad
DK0881908T3 (da) Anvendelse af fiberblastvækstfaktorer til stimulering af knoglevækst
GR3030141T3 (en) Diphtheria toxin receptor-binding region.
ATE346083T1 (de) Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung
ES2123582T3 (es) Proteina con capacidad de formacion de huesos y procedimiento para su produccion.
DE60025830D1 (de) Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung
DK29889D0 (da) Heparinbindende hjernemitogener, deres fremstilling og anvendelse
WO2002004480A3 (en) Connective tissue growth factor-2
EP0832109A4 (en) FACTOR-2, HOMOLOGY OF THE FIBROBLASTS GROWTH FACTOR AND METHOD FOR ITS APPLICATION
RU95108616A (ru) Способ лечения верхней ретро- или микрогнатии, осложненной расщелиной твердого неба и альвеолярного отростка
WO2001075008A3 (fr) Nouveau polypeptide, protéine hélicase-anneau-hélicase 11, et polynucleotide codant pour ce polypeptide
RU95109007A (ru) Способ лечения верхней ретро- или микрогнатии
RU97116344A (ru) Способ удлинения конечности
MX9600765A (es) Proteina y metodos para producir la proteina.